Amyl Therapeutics Alternatives & Competitors
12 companies similar to Amyl Therapeutics — Restoring clarity in amyloid diseases
Companies similar to Amyl Therapeutics
ProteoTech
Advancing Therapeutics and Diagnostics for Amyloid Diseases Since 1996
ND BioSciences
Innovating through embracing complexity
Switzerland
BIORCHESTRA Co., Ltd.
We develop novel RNA-based therapeutics that will be able to bring about a paradigm shift...
Cambridge, United States
Attralus
Attralus is a biopharmaceutical company creating transformative medicines for patients wit...
Naples, United States
Rival Readout
Competing with Amyl Therapeutics? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
FimmCyte
First disease modifying treatment for Endometriosis.
Basel, Switzerland
BioAge Labs
We are harnessing the biology of human aging to develop novel targets and therapies for me...
Emeryville, United States
Sudo Biosciences
Developing precision TYK2 therapeutics.
Carmel, United States
Merck & Co., Inc.
Merck develops and produces medicines, vaccines, biologic therapies and animal health prod...
Nitrase Therapeutics
Pioneering Nitrase Biology and Medicines
Brisbane, United States
Sciwind Biosciences
Pioneering treatments to empower physicians in addressing metabolic disorders with advance...
Dianthus Therapeutics, Inc.
Building a leading biotech company focused in severe autoimmune diseases.
United States
Senexis Limited
Small-molecule therapies targeting amyloid protein toxicity
Cambridge, United Kingdom
About Amyl Therapeutics
Amyl Therapeutics is a preclinical-stage biotechnology company founded in 2020 and based in Belgium. The company's mission revolves around pioneering a breakthrough approach to treating severe peripheral amyloid protein misfolding diseases. With the slogan "Restoring clarity in amyloid diseases," Amyl Therapeutics aims...
Development of Pan-Amyloid Immunotherapy for amyloid-mediated diseases
Patients suffering from amyloid-mediated diseases, healthcare providers, pharmaceutical companies, research institutions
Therapeutics, Preclinical Research, Neurodegenerative Diseases, Protein Misfolding, Amyloid Diseases, Drug Development, Biochemistry, Medical Research, Neuroscience, Pharmaceuticals, Biopharmaceutical Research, Clinical Trials, Disease Treatment, Medical Innovation
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Amyl Therapeutics: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Amyl Therapeutics on 13 Apr 2025. The 12 companies listed here were last checked between 11 Sep 2024 and 2 Sep 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
